BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 23408758)

  • 21. Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia.
    Schlecht NF; Platt RW; Duarte-Franco E; Costa MC; Sobrinho JP; Prado JC; Ferenczy A; Rohan TE; Villa LL; Franco EL
    J Natl Cancer Inst; 2003 Sep; 95(17):1336-43. PubMed ID: 12953088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of TERC amplification in cervical epithelial cells for the diagnosis of high-grade cervical lesions and invasive cancer: a multicenter study in China.
    Jiang J; Wei LH; Li YL; Wu RF; Xie X; Feng YJ; Zhang G; Zhao C; Zhao Y; Chen Z
    J Mol Diagn; 2010 Nov; 12(6):808-17. PubMed ID: 20864639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human papillomavirus multiplex ligation-dependent probe amplification assay for the assessment of viral load, integration, and gain of telomerase-related genes in cervical malignancies.
    Theelen W; Litjens RJ; Vinokurova S; Haesevoets A; Reijans M; Simons G; Smedts F; Herrington CS; Ramaekers FC; von Knebel Doeberitz M; Speel EJ; Hopman AH
    Hum Pathol; 2013 Nov; 44(11):2410-8. PubMed ID: 23968641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of chromosome 3q26 gain in predicting progression of cervical dysplasia.
    Rodolakis A; Biliatis I; Symiakaki H; Kershnar E; Kilpatrick MW; Haidopoulos D; Thomakos N; Antsaklis A
    Int J Gynecol Cancer; 2012 Jun; 22(5):742-7. PubMed ID: 22635026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repeat cytology and human papillomavirus screening strategies in detecting preinvasive cervical lesions.
    Li K; Yin R
    Medicine (Baltimore); 2015 Feb; 94(5):e435. PubMed ID: 25654377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of quantity and staining pattern of human papillomavirus (HPV)-infected epithelial cells in thin-layer cervical specimens using optimized HPV-CARD assay.
    Algeciras-Schimnich A; Policht F; Sitailo S; Song M; Morrison L; Sokolova I
    Cancer; 2007 Oct; 111(5):330-8. PubMed ID: 17724679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Relationship between cervical lesions and the type-specific viral load of high risk HPV reflected by the Ct value of Cobas 4800 HPV system].
    Duan LF; Du H; Xiao AM; Wang C; Huang X; Zhao MF; Men HJ; Wu RF
    Zhonghua Fu Chan Ke Za Zhi; 2019 Jul; 54(7):458-463. PubMed ID: 31365958
    [No Abstract]   [Full Text] [Related]  

  • 28. Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.
    Juric D; Mahovlić V; Rajhvajn S; Ovanin-Rakić A; Skopljanac-Macina L; Barisić A; Projić IS; Babić D; Susa M; Corusić A; Oresković S
    Coll Antropol; 2010 Mar; 34(1):19-24. PubMed ID: 20432728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg.
    Latsuzbaia A; Hebette G; Fischer M; Arbyn M; Weyers S; Vielh P; Schmitt F; Mossong J
    Diagn Cytopathol; 2017 May; 45(5):384-390. PubMed ID: 28247516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical significance of human telomerase RNA gene (hTERC) amplification in cervical squamous cell lesions detected by fluorescence in situ hybridization.
    Jin Y; Li JP; He D; Tang LY; Zee CS; Guo SZ; Zhou J; Chen JN; Shao CK
    Asian Pac J Cancer Prev; 2011; 12(5):1167-71. PubMed ID: 21875260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 3q26 (hTERC) gain studied by fluorescence in situ hybridization as a persistence-progression indicator in low-grade squamous intraepithelial lesion cases.
    Alameda F; Espinet B; Corzo C; Muñoz R; Bellosillo B; Lloveras B; Pijuan L; Gimeno J; Salido M; Solé F; Carreras R; Serrano S
    Hum Pathol; 2009 Oct; 40(10):1474-8. PubMed ID: 19540557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Significance of p16/Ki-67 double immunocytochemical staining in cervical cytology ASCUS, LSIL, and ASC-H].
    Wu Y; Zhao J; Hu J; Wu XW; Zhu LR
    Zhonghua Fu Chan Ke Za Zhi; 2017 Nov; 52(11):734-739. PubMed ID: 29179267
    [No Abstract]   [Full Text] [Related]  

  • 33. Use of hTERT and HPV E6/E7 mRNA RT-qPCR TaqMan assays in combination for diagnosing high-grade cervical lesions and malignant tumors.
    Wang HY; Park S; Kim S; Lee D; Kim G; Kim Y; Park KH; Lee H
    Am J Clin Pathol; 2015 Mar; 143(3):344-51. PubMed ID: 25696792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Use of high-risk human papillomavirus DNA testing to deal with atypical squamous cells undetermined significance and low squamous intraepithelial lesion].
    Guo YL; You K; Geng L; Zhang XW; Shen XY; Yao YJ; Fan XH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 38(5):480-2. PubMed ID: 17068618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Combining high-risk human papillomavirus DNA test and cytological test to detect early cervical dysplasia].
    Qian DY; Cen JM; Wang D; Zeng RH; Lin AH; Shu YH; Hong DH; Huang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):34-7. PubMed ID: 16635326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of genomic amplification of the human telomerase RNA component gene in the screening of cervical lesions].
    Jiang J; Tu Z; Zhang G; Li JR; Zhao LJ; Zhao C; Cui SH; Li XP; Chen Z; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2008 Nov; 43(11):849-53. PubMed ID: 19087570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion: diagnostic performance, human papillomavirus testing, and follow-up results.
    Srodon M; Parry Dilworth H; Ronnett BM
    Cancer; 2006 Feb; 108(1):32-8. PubMed ID: 16136595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical value of p16
    Song FB; Du H; Xiao AM; Wang C; Huang X; Yan PS; Liu ZH; Qu XF; Belinson JEROMEL; Wu RF
    Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):784-790. PubMed ID: 33228350
    [No Abstract]   [Full Text] [Related]  

  • 39. Application of hTERC in thinprep samples with mild cytologic abnormality and HR-HPV positive.
    Li Y; Zeng WJ; Ye F; Wang XY; Lü WG; Ma D; Wei LH; Xie X
    Gynecol Oncol; 2011 Jan; 120(1):73-83. PubMed ID: 21035173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genomic integration of oncogenic HPV and gain of the human telomerase gene TERC at 3q26 are strongly associated events in the progression of uterine cervical dysplasia to invasive cancer.
    Hopman AH; Theelen W; Hommelberg PP; Kamps MA; Herrington CS; Morrison LE; Speel EJ; Smedts F; Ramaekers FC
    J Pathol; 2006 Dec; 210(4):412-9. PubMed ID: 17054308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.